Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-12-02 16:46:38 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s40257-025-00975-3
文献链接: https://link.springer.com/10.1007/s40257-025-00975-3
其他信息:
出版社: Springer Science and Business Media LLC
作者: Alan D. Irvine; Vimal H. Prajapati; Emma Guttman-Yassky; Eric L. Simpson; Kim A. Papp; Andrew Blauvelt; Chia-Yu Chu; H. Chih-ho Hong; Linda F. Stein Gold; Marjolein de Bruin-Weller; Thomas Bieber; Kenji Kabashima; David Rosmarin; Cristina Sancho; Brian M. Calimlim; Ayman Grada; Yang Yang; Xiaoqiang Wu; Gweneth Levy; Eliza M. Raymundo; Henrique D. Teixeira; Jonathan I. Silverberg
全文下载地址: https://link.springer.com/content/pdf/10.1007/s40257-025-00975-3.pdf
